Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
13.77
-0.33 (-2.34%)
At close: Oct 29, 2025, 4:00 PM EDT
14.00
+0.23 (1.65%)
After-hours: Oct 29, 2025, 7:00 PM EDT
Takeda Pharmaceutical Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Takeda Pharmaceutical in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Takeda Pharmaceutical.
Recommendation Trends
| Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $30 → $20 | Buy | Maintains | $30 → $20 | +45.24% | May 16, 2023 |
| TD Cowen | TD Cowen | Buy Maintains $24 → $30 | Buy | Maintains | $24 → $30 | +117.86% | Apr 4, 2023 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $20 | Hold → Strong Buy | Upgrades | $20 | +45.24% | Mar 16, 2023 |
| Cowen & Co. | Cowen & Co. | Hold → Buy Upgrades $21 → $24 | Hold → Buy | Upgrades | $21 → $24 | +74.29% | Jul 19, 2022 |
| Cowen & Co. | Cowen & Co. | Hold Initiates $20 | Hold | Initiates | $20 | +41.61% | Nov 1, 2019 |
Financial Forecast
Revenue This Year
4.59T
from 4.58T
Increased by 0.14%
Revenue Next Year
4.61T
from 4.59T
Increased by 0.58%
EPS This Year
155.64
from 67.23
Increased by 131.51%
EPS Next Year
197.35
from 155.64
Increased by 26.80%
Financial currency is JPY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.9T | 5.0T | |
| Avg | 4.6T | 4.6T | |
| Low | 4.3T | 4.2T |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.2% | 8.3% | |
| Avg | 0.1% | 0.6% | |
| Low | -6.9% | -7.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 205.28 | 268.50 | |
| Avg | 155.64 | 197.35 | |
| Low | 132.59 | 98.98 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 205.3% | 72.5% | |
| Avg | 131.5% | 26.8% | |
| Low | 97.2% | -36.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.